Ravulizumab (Synonyms: ALXN1210) |
| Catalog No.GC69803 |
Ravulizumab (ALXN1210) is a humanized monoclonal antibody that binds specifically and with high affinity to human complement protein C5. Ravulizumab can be used in the research of paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, and myasthenia gravis.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1803171-55-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Review for Ravulizumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Ravulizumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *